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Introduction
The first successful lung transplantation has been performed 
in 1983 (1). Since then it is the ultimate therapeutic 
option for inherited or acquired end stage lung diseases 
such as cystic fibrosis (CF), primary pulmonary arterial 
hypertension and pulmonary fibrosis, if maximum medical 
and surgical strategies fail (2).
Common complications after lung transplantation are 
early graft dysfunction (primary graft dysfunction (PGD), 
renal failure (3), infections (4) and blood loss (5), the latter 
being influenced by various factors in thoracic surgery (6). 
Infections and renal failure are not only adverse effects 
after lung transplant, but also acknowledged risk factors 
for decreased 1-year survival after lung transplantation (7). 
Growing evidence underlines that blood transfusions are 
causing adverse effects (8). Patient blood management aims 
to minimize allogeneic blood transfusions in order to save 
cost and prevent negative consequences (9,10). Examples 
for the latter are transfusion-associated circulatory overload 
(TACO) (11), PGD (12) and transfusion-related acute 
lung injury (TRALI) (13). Nowadays, blood transfusions 
are acknowledged to prolong hospital stay and increase 
mortality after lung transplantation (14). In addition, the 
direct economic effect should not be underestimated as 
the cost of one unit of packed red blood cells (PRBC) in 
the United States ranges between US$700–1,200 (15). 
Therefore, predicting, evaluating, and finally reducing 
blood loss in lung transplantation might contribute to lower 
cost, reduced morbidity and better survival. 
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Predictors of blood loss in other surgical 
procedures
Identifying predictors of blood loss is usually not the goal 
per se. However, predictors of blood loss may contribute 
to make surgery more efficient and finally to reduce the 
amount of required transfusions. 
Orthopedic surgery
In orthopedic surgery, Park et al. identified male sex, 
preoperative autologous blood donations, and a Charlson 
comorbidity score of >3 to be independently linked to 
an increased perioperative blood loss in both total knee 
arthroplasty and total hip arthroplasty (16). In total hip 
arthroplasty, regional anesthesia was associated with 
reduced blood loss (16). While it is clear, that some of the 
predictors mentioned might not be influenced (e.g., the 
patient’s gender), others can be adapted easily, for example 
the type of anesthesia applied.
Liver surgery
For liver surgery, independent predictors of blood loss 
and blood transfusion include preoperative hematocrit, 
low platelets, and a high INR (17). Other studies have 
described a body mass index (BMI) of ≥23 kg/m2, low 
prothrombin activity amongst others to be predictive 
for blood loss (18-20). In particular in orthotopic liver 
transplantation, Mangus et al. identified age, MELD (model 
of end-stage liver disease) score, preoperative hemoglobin, 
initial fibrinogen, initial central venous pressure, and total 
anesthesia time as predictors of blood loss (21).
Cardiac surgery
In a retrospective study in cardiothoracic surgery on 
cardiopulmonary bypass (CPB), increased BMI, and 
preoperative hemoglobin levels were associated with 
reduced use of PRBC, whereas a higher EuroSCORE 
(European System for Cardiac Operative Risk Evaluation), 
longer CPB duration, and a higher fluid balance at 6 hours 
after surgery were correlated to an increased use of red 
blood cells (22). Intraoperative body temperature had no 
impact on red blood cell requirements (22). These findings 
might be of particular interest for the numerous patients 
undergoing lung transplantation on CPB.
Predictors of blood loss during lung 
transplantation
Lung transplantation is a well-established procedure for 
end stage lung diseases and has been studied thoroughly. 
However, the predictors of blood loss during the procedure 
have not been investigated thoroughly so far.
Triulzi et al. showed that transplantations on CPB, 
required more perioperative blood products (23). They 
found less transfusion requirements in single-lung 
procedures independent of CPB use. This was attributed 
to the greater surgical complexity of double compared to 
single-lung transplantations. In addition, the use of CBP is 
more frequent during double-lung transplant procedures.
Wang and colleagues confirmed the results of Triulzi (23) 
and demonstrated less requirement of PRBC, FFP, and 
platelets during lung transplantation in single-lung 
transplantation (5). Furthermore, they discovered that the 
patient’s diagnosis had an impact on the amount of blood 
products required. Eisenmenger’s syndrome, a severe 
form of pulmonary hypertension, and CF patients more 
frequently needed perioperative blood products, partly 
because these patients require a double lung transplant. 
Moreover, many Eisenmenger’s syndrome and CF patients 
have previously undergone cardiac or thoracic surgery, 
thus these two subgroups often underwent re-sternotomy, 
which is associated with increased blood loss (24). In the 
same study, adhesions have been referred to contribute to 
increased blood loss. Vascularized adhesions are common in 
CF patients. They are a result of long lasting inflammatory 
processes and contribute to a higher blood loss complicating 
surgery (6,25).
Many lung-transplant candidates present with low cardiac 
output, refractory hypoxemia, and other cardiopulmonary 
instabilities. Thus, extracorporeal circulation support 
may be quite commonly required in the form of CPB or 
extracorporeal membrane oxygenation (ECMO). CPB 
during pulmonary transplantation increases the risks of 
early graft dysfunction and bleeding (26-28). The impact 
of ECMO on blood loss needs to be established. There are 
studies that suggest ECMO might provide a better view in 
the operation field for the surgeon, and therefore contribute 
to less transfusions (29,30), however, there are also 
contradictory studies that held ECMO to be responsible for 
blood loss and blood transfusion requirements (31), while 
other studies do not show any difference between CPB and 
ECMO (32). Hence, the role of extracorporeal circulation 
3847Journal of Thoracic Disease, Vol 10, No 6 June 2018
© Journal of Thoracic Disease. All rights reserved. J Thorac Dis 2018;10(6):3845-3848jtd.amegroups.com
support in blood loss in lung transplantations is not yet 
completely understood.
Discussion
Preventing and reducing blood loss decreases morbidity and 
mortality in surgery and leads to shorter hospitalization (33). 
The resulting economic impact cannot be neglected. 
Although survival rates, surgical techniques and 
management of bleeding in lung transplantation have 
improved over the years and although awareness of severe 
adverse effects of allogeneic blood product transfusion 
has grown, significant predictors of blood loss have been 
sparsely identified. 
Double-lung transplant is associated with an extended 
use of blood products when compared to single-lung 
procedures. This may be a result of longer duration and 
augmented complexity of surgery. The underlying disease, 
Eisenmenger’s syndrome and CF have also impact on blood 
loss, due to the reasons discussed previously. The impact 
of extracorporeal circulation support on blood loss remains 
contradictory. 
Other potential predictors, for instance BMI, preoperative 
hemoglobin, hematocrit, INR, total surgical and anesthesia 
time, or risk scores such as the Charlson Comorbidity Index 
and other important variables of hematology have been 
investigated in other settings and should be evaluated for 
lung transplant surgery (34). 
Once the risk factors are identified, strategies can be 
developed, that either target the risk factors or specific steps 
of the lung transplant procedure in order to minimize blood 
loss and finally improve patient outcome.
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